Health as a Trade Issue: How the Campaign for South African Access brought the Right to Health to the WTO
Keywords:
Transnational Advocacy Networks, international norms, HIV/AIDS, TRIPSAbstract
Transnational advocacy networks played a crucial role in the acceptance of the right to health as a trade concern that takes precedence over intellectual property protections. The development and influence of this norm is reflected in international responses to the 1998-2001 South African litigation over access to medicines.
References
't Hoen, Ellen. "TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha
and Beyond." Medecins Sans Frontieres Access Campaign. July 24, 2003. Accessed March 24, 2015. http://www.msfaccess.org/sites/default/files/MSF_assets/Access/Docs/ACCESS_article_TRIPSPatentsDohaBeyond_ENG_2003.pdf.
AIDS Coalition to Unleash Power. “Aids Activists Disrupt Al Gore's Announcement Of
Presidential Candidacy: Protestors Demand Global Access To Anti-HIV Drugs And An End To Vice-President's Bullying Of South Africa.” Accessed March 27, 2015. http://www.actupny.org/actions/gorezaps.html.
Björkdahl, Annika. “Norms in International Relations: Some Conceptual and Methodological
Reflections.” Cambridge Review of International Affairs 15:1 (2002): 19. http://go.utlib.ca/cat/7692839.
Brysk, Alison. Human Rights and Private Wrongs: Constructing Global Civil Society. New
York: Routledge, 2005.
Clinton, William. Remarks to the luncheon in honor of the Ministers attending the Meeting of
the World Trade Organization. December 1, 1999. White House Office of the Press Secretary. Found online at: http://www.staff.city.ac.uk/p.willetts/PIE-DOCS/CLNT1299.HTM.
Consumer Project on Technology. “MSF, HAI, CPT Press Statement Seattle.” December 2,
Accessed March 26, 2015. http://www.cptech.org/ip/health/seattle.html.
Dobson, Roger. “Drug company lobbyist joins Oxfam’s cheap drugs campaign.” BMJ : British
Medical Journal, 322.7293 (2001):1011. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120172/.
Dunn, Alan and Bill Fennell to the Film and Television Action Committee. April 23, 2004.
Memorandum. Stewart and Stewart. Accessed March 26, 2015. http://ftac.net/7-Special_301.pdf.
Earnshaw, David. Speech at the Amsterdam Conference on Increasing Access to Essential Drugs
in a Globalized Economy. November 29, 1999. Health Action International. http://www.haiweb.org/campaign/novseminar/earnshaw.html.
European Commission (DG 1). Note on the WHO’s Revised Drug Strategy. October 5, 1998.
/D/3/BW D (98). Found online at: http://keionline.org/node/924.
Executive Order No. 13155, 65 Federal Register 30521 (May 10, 2000).
https://federalregister.gov/a/00-12177.
Forman, Lisa. "A Transformative Power? The Role of the Human Right to Medicines in
Accessing AIDS Medicines: International Human Rights Law, TRIPS and the South African Experience." Order No. NR27989, University of Toronto (Canada), 2007. http://search.proquest.com/docview/304751804?accountid=14771.
Fisher, William W III, and Cyril Rigamonti. “The South Africa AIDS Controversy: A Case
Study in Patent Law and Policy.” Law of business and patents working paper, Harvard Law School, February 10, 2005. http://cyber.law.harvard.edu/people/tfisher/South%20Africa.pdf.
General Agreement on Tariffs and Trade. Agreement on Trade-Related Aspects of Intellectual
Property Rights, Annex 1C of the Marrakesh Agreement Establishing the World Trade Organization, signed in Marrakesh, Morocco on April 15, 1994. Accessed March 25,
https://www.wto.org/english/docs_e/legal_e/legal_e.htm#TRIPs.
Klotz, Audie. “Norms reconstituting interests: global racial equality and U.S. sanctions against
South Africa.” International Organization 49:3 (1995), 452. http://go.utlib.ca/cat/7719858.
McInnes, Colin, Adam Kamraadt-Scott, Kelley Lee, Anne Roemer-Mahler, Simon Rushton, and
Owain David Williams. The Transformation of Global Health Governance, New York: Palgrave Macmillan, 2014.
Legal Information Institute. “Amicus Curiae.” Accessed April 1, 2015.
https://www.law.cornell.edu/wex/amicus_curiae.
MSF Access Campaign. “39 Drug Companies vs South Africa: People die for lack of affordable
drugs as inhumane industry ignores reality.” March 5, 2001. http://www.msfaccess.org/about-us/media-room/press-releases/39-drug-companies-vs-south-africa-people-die-lack-affordable.
MSF Access Campaign. “Big Pharma versus Nelson Mandela.” Last modified January 2009.
Accessed March 26, 2015. http://www.msfaccess.org/content/1998-big-pharma-versus-nelson-mandela.
MSF Access Campaign. “Drop the Case! Support the Struggle for Medicines in South Africa.”
March 8, 2001. http://www.msfaccess.org/about-us/media-room/press-releases/drop-case-support-struggle-medicines-south-africa.
MSF Access Campaign. “Pharmaceutical Industry Must Stop Obstructing Access to Medicine in
South Africa.” Mar 1, 2001. http://www.msfaccess.org/about-us/media-room/press-releases/pharmaceutical-industry-must-stop-obstructing-access-medicine
Russel, Sabin. “New Crusade to Lower AIDS Drug Costs/ Africa’s needs at odds with firms’
profit motive.” SF Gate. May 24, 1999. http://www.sfgate.com/health/article/New-Crusade-To-Lower-AIDS-Drug-Costs-Africa-s-2929307.php.
Sell, Susan K. and Aseem Prakash. "Using Ideas Strategically: The Contest between Business
And NGO Networks in Intellectual Property Rights." International Studies
Quarterly 48:1 (2004): 143-175. http://resolver.scholarsportal.info/resolve/00208833/v48i0001/143_uistcbnniipr.xml.
Stoeva, Preslava. New Norms and Knowledge in World Politics: Protecting People, Intellectual
Property and the Environment. New York: Routledge, 2010.
Swarns, Rachel L. “Drug makers Drop South Africa Suit Over AIDS Medicine.” The New York
Times. April 20, 2001. Accessed March 24, 2015.
http://www.nytimes.com/2001/04/20/world/drug-makers-drop-south-africa-suit-over-aids-medicine.html.
Treatment Action Campaign. “5 March 2001: International Day of Action against
Pharmaceutical Company Profiteering.” Accessed March 27, 2015. http://www.tac.org.za/Documents/Other/mar5act.htm.
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
